Evidence map›Paper›PMID 27916850›Full record

ArticleMolecules (Basel, Switzerland)2016

Multi-Layer Identification of Highly-Potent ABCA1 Up-Regulators Targeting LXRβ Using Multiple QSAR Modeling, Structural Similarity Analysis, and Molecular Docking.

Meimei Chen, Fafu Yang, Jie Kang, Xuemei Yang, Xinmei Lai, Yuxing Gao

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Meimei ChenCollege of Chemistry and Chemical Engineering, Fujian Normal University, Fuzhou 350007, Fujian, China. chenmeimei1984@163.com.
Fafu YangCollege of Chemistry and Chemical Engineering, Fujian Normal University, Fuzhou 350007, Fujian, China. yangfafu@fjnu.edu.cn.
Jie KangCollege of Traditional Chinese Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, Fujian, China. meinuohua2007@163.com.
Xuemei YangCollege of Traditional Chinese Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, Fujian, China. mei_tcm@163.com.
Xinmei LaiCollege of Traditional Chinese Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, Fujian, China. keerer1990@163.com.
Yuxing GaoCollege of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, Fujian, China. gaoxingchem@xmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, in silico approaches, including multiple QSAR modeling, structural similarity analysis, and molecular docking, were applied to develop QSAR classification models as a fast screening tool for identifying highly-potent ABCA1 up-regulators targeting LXRβ based on a series of new flavonoids. Initially, four modeling approaches, including linear discriminant analysis, support vector machine, radial basis function neural network, and classification and regression trees, were applied to construct different QSAR classification models. The statistics results indicated that these four kinds of QSAR models were powerful tools for screening highly potent ABCA1 up-regulators. Then, a consensus QSAR model was developed by combining the predictions from these four models. To discover new ABCA1 up-regulators at maximum accuracy, the compounds in the ZINC database that fulfilled the requirement of structural similarity of 0.7 compared to known potent ABCA1 up-regulator were subjected to the consensus QSAR model, which led to the discovery of 50 compounds. Finally, they were docked into the LXRβ binding site to understand their role in up-regulating ABCA1 expression. The excellent binding modes and docking scores of 10 hit compounds suggested they were highly-potent ABCA1 up-regulators targeting LXRβ. Overall, this study provided an effective strategy to discover highly potent ABCA1 up-regulators.

Indexed as

Drug DesignQuantitative Structure-Activity RelationshipAtherosclerosisATP Binding Cassette Transporter 1Binding SitesCholesterol, HDLComputer SimulationDatabases, ChemicalFlavonoidsHumansLiver X ReceptorsModels, MolecularMolecular Docking SimulationNeural Networks, ComputerSupport Vector MachineABCA1 protein, humanATP Binding Cassette Transporter 1Cholesterol, HDLFlavonoidsLiver X ReceptorsABCA1LXRβmolecular dockingmolecular modelingQSARsimilarity analysis

Identifiers

PMID27916850
PMCPMC6273961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.